VERSANT VENTURE CAPITAL VI, L.P. sold 10.2% of their position (200K shares) of LENZ THERAPEUTICS, INC. on the open market
Open‑market sale worth $6.09M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/1/2025ACC: 0000950170-25-092373
10% Owner
Since Jun 2021
-200K
Net shares
Net seller
$6.09M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
200K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−200K
Price / share
$30.46
Trade value
$6.09M
% of position
10.2%
6/27/2025
1.97M→1.77M
Total
Net shares
−200K
Net value
-$6.09M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/27/2025 | S · Sale | −200K | $30.46 | $6.09M | 10.2% | 1.97M | 1.77M |
| Total | −200K | -$6.09M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned842.16K
Common Stock
IndirectShares owned1.05M
Total
1.89M indirect1.89M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 842.16K | Indirect |
| Common Stock | 1.05M | Indirect |
| Total | 1.89M | 1.89M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported